Terms: = Endocrine gland cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
29 results:
1. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract] [Full Text] [Related]
2. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma.
Qian Y; Gong Y; Liu Y; Chen Y; Wang R; Dai Z; Zou X; Tasiheng Y; Luo G; Lin X; Wang X; Cheng H; Yu X; Liu C
J Immunol Res; 2022; 2022():7353572. PubMed ID: 35910854
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.
Wen X; Jin Q; Cen X; Qiu M; Wu Z
World J Surg Oncol; 2022 Apr; 20(1):106. PubMed ID: 35365171
[TBL] [Abstract] [Full Text] [Related]
4. Rate of pancreatic cancer following a negative endoscopic ultrasound and associated factors.
King D; Kamran U; Dosanjh A; Coupland B; Mytton J; Leeds JS; Nayar M; Patel P; Oppong KW; Trudgill NJ
Endoscopy; 2022 Nov; 54(11):1053-1061. PubMed ID: 35359019
[TBL] [Abstract] [Full Text] [Related]
5. Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study.
Kuji S; Harada M; Yoshioka N; Kajiyama H; Satoh T; Mikami M; Shozu M; Enomoto T; Osuga Y; Suzuki N
J Obstet Gynaecol Res; 2022 Mar; 48(3):806-816. PubMed ID: 34951514
[TBL] [Abstract] [Full Text] [Related]
6. A UK based two-centre review of multifocality and its role in the treatment of papillary thyroid cancer.
Li LQ; Hey SY; Andreeva D; Tornari C; Sawant R; Harding NE; Adamson R; Hay A; Simo R; Nixon IJ
Eur J Surg Oncol; 2022 Jan; 48(1):14-20. PubMed ID: 34253424
[TBL] [Abstract] [Full Text] [Related]
7. Mucinous cystic neoplasms of the pancreas in the modern era. Experience with 707 patients.
Ahmad M; Maegawa FB; De La Rosa E; Davis B; Tyroch A; Konstantinidis IT
Am J Surg; 2020 Dec; 220(6):1433-1437. PubMed ID: 32938530
[TBL] [Abstract] [Full Text] [Related]
8. Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.
Chen C; Xu Y; Huang X; Mao F; Shen S; Xu Y; Sun Q
Medicine (Baltimore); 2020 Aug; 99(32):e21560. PubMed ID: 32769897
[TBL] [Abstract] [Full Text] [Related]
9. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm.
Mungo B; Croce C; Oba A; Ahrendt S; Gleisner A; Friedman C; Schulick RD; Del Chiaro M
Ann Surg Oncol; 2021 Mar; 28(3):1533-1542. PubMed ID: 32743713
[TBL] [Abstract] [Full Text] [Related]
10. Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Kwon JH; Yi JW
Surgery; 2021 Jan; 169(1):43-49. PubMed ID: 32641280
[TBL] [Abstract] [Full Text] [Related]
11. Effects of miR-492 on migration, invasion, EMT and prognosis in ovarian cancer by targeting SOX7.
Wang Z; Liu Y; Wang M; Zhao J
J BUON; 2020; 25(2):797-804. PubMed ID: 32521870
[TBL] [Abstract] [Full Text] [Related]
12. Pulmonary and overall healthcare utilization after childhood and young adult thyroid cancer.
Di Giuseppe G; Zuk AM; Wasserman JD; Pole JD
Endocr Relat Cancer; 2020 Jun; 27(6):391-402. PubMed ID: 32252026
[TBL] [Abstract] [Full Text] [Related]
13. [Prognostic value of important driver gene mutations in patients with radical resection of pancreatic cancer].
Shen J; Gao SZ; Wang H; Shi XH; Li B; Pan YQ; Shen S; Shao Z; Guo SW; Jin G
Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):840-847. PubMed ID: 31694133
[No Abstract] [Full Text] [Related]
14. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
[TBL] [Abstract] [Full Text] [Related]
15. [A retrospective study of tumor and fertility outcomes after fertility-sparing surgical treatment of patients with borderline ovarian tumors].
Liu F; Hu DH; Zhang YF; Wang B; Huang K; Wang CY; Xia XY
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3699-3703. PubMed ID: 29325322
[No Abstract] [Full Text] [Related]
16. Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.
Zhu J; Wen H; Bi R; Wu Y; Wu X
J Gynecol Oncol; 2017 Nov; 28(6):e77. PubMed ID: 29027395
[TBL] [Abstract] [Full Text] [Related]
17. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
[TBL] [Abstract] [Full Text] [Related]
18. The histopathologic type predicts survival of patients with ampullary carcinoma after resection: A meta-analysis.
Zhou Y; Li D; Wu L; Si X
Pancreatology; 2017; 17(2):273-278. PubMed ID: 28131524
[TBL] [Abstract] [Full Text] [Related]
19. Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms.
Kaltenborn A; Matzke S; Kleine M; Krech T; Ramackers W; Vondran FW; Klempnauer J; Bektas H; Schrem H
J Surg Oncol; 2016 Feb; 113(2):194-202. PubMed ID: 26709239
[TBL] [Abstract] [Full Text] [Related]
20. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic cancer Undergoing Chemotherapy.
Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
[TBL] [Abstract] [Full Text] [Related]
[Next]